Multidrug resistance in pseudomonas aeruginosa isolated from nosocomial respiratory and urinary infections in aleppo, Syria

Journal of Infection in Developing Countries

Volumn 9, Issue 2, 2015, Pages 210-213

  Mahfoud, Maysa ^a   Al Najjar, Mona ^b   Hamzeh, Abdul Rezzak ^a  

^a UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

^b Centralized Clinical Microbiological Laboratory in Albasel and Ibn Rushd Hospitals   (Syrian Arab Republic)

Author keywords

Multidrug resistance; Nosocomial infections; Pseudomonas aeruginosa; Respiratory infections; Syria; Urinary infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFOTAXIME; CIPROFLOXACIN; CLARITHROMYCIN; COLISTIN; DOXYCYCLINE; GENTAMICIN; NITROFURANTOIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CHEMICAL ANALYSIS; CROSS-SECTIONAL STUDY; DISK DIFFUSION; FEMALE; HOSPITAL INFECTION; HUMAN; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SYRIAN ARAB REPUBLIC; URINARY TRACT INFECTION; CROSS INFECTION; DRUG EFFECTS; HOSPITAL; HOSPITAL PATIENT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREVALENCE; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; URINARY TRACT INFECTIONS;

PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; INPATIENTS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SYRIA; URINARY TRACT INFECTIONS;

EID: 84923133975     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.5643     Document Type: Article

References (14)

1. O'Sullivan BP, Freedman SD (2009) Cystic fibrosis. Lancet 373: 1891-1904. doi: 10.1016/S0140-6736(09)60327-5.
2. Gillespie S, Hawkey PM (2006) Principles and Practice of Clinical Bacteriology, Second Edition, Chichester, UK: Wiley. 620 p.
3. Zavascki AP, Barth AL, Fernandes JF, Moro AL, Gonçalves AL, Goldani LZ (2006) Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: A prospective observational study. Crit Care 10: R114.
4. Vitkauskienė A, Skrodenienė E, Dambrauskienė A, Macas A, Sakalauskas R (2010) Pseudomonas aeruginosa bacteremia: Resistance to antibiotics, risk factors, and patient mortality. Medicina (Kaunas) 46: 490-495.
5. Mosel M, Li L, Drlica K, Zhao X (2013) Superoxide-mediated protection of Escherichia coli from antimicrobials. Antimicrob Agents Chemother 57: 5755-5759. doi: 10.1128/AAC.00754-13.
6. Strateva T, Yordanov D (2009) Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 58: 1133-1148. doi: 10.1099/jmm.0.009142-0.
7. Qiu X, Kulasekara BR, Lory S (2009) Role of Horizontal Gene Transfer in the Evolution of Pseudomonas aeruginosa Virulence. Genome Dyn 6: 126-139. doi: 10.1159/000235767.
8. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing. NCCLS documents 100-112. CLSI: Wayne, PA.
9. Sader HS, Farrell DJ, Castanheira M, Flamm RK, Jones RN (2014) Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12). J Antimicrob Chemother 69: 2713-2722.
10. Shahcheraghi F, Badmasti F, Feizabadi MM (2014) Molecular characterization of class 1 integrons in MDR Pseudomonas aeruginosa isolated from clinical settings in Iran, Tehran. FEMS Immunol Med Microbiol 58: 421-425. doi: 10.1111/j.1574-695X.2009.00636.x.
11. Vojtová V, Kolár M, Hricová K, Uvízl R, Neiser J, Blahut L, Urbánek K (2011) Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units. New Microbiol 34: 291-298.
12. Van Eldere J (2003) Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 51: 347-352.
13. D'Agata EM (2004) Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: A 9-year surveillance study. Infect Control Hosp Epidemiol 25: 842-846.
14. Malik M, Li L, Zhao X, Kerns RJ, Berger JM, Drlica K (2014) Lethal synergy involving bicyclomycin: An approach for reviving old antibiotics. J Antimicrob Chemother 69: 3227-3235.